Here's Why You Should Consider Buying Jazz Pharmaceuticals' Stock

Jazz Pharmaceuticals (JAZZ) focuses on making drugs for neuroscience and oncology. The company derives most of its revenues from its sleep disorder drugs — Xywav and Xyrem. Xywav is a low-sodium formulation of Jazz's legacy drug, Xyrem. It also has a rapidly growing oncology portfolio. Jazz's revenues continue to benefit from strong demand for newer drugs like Xywav, Epidiolex and Rylaze. Jazz has also regularly boosted its commercial portfolio and pipeline through acquisitions. Jazz boasts a promising pipe ...